Evidence map›Paper›PMID 29125184›Full record

ArticleEpilepsia2018

Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.

Leonie Runtz, Benoit Girard, Marion Toussenot, Julie Espallergues, Alexis Fayd'Herbe De Maudave, Alexandre Milman, Frederic deBock, Chaitali Ghosh, Nathalie C Guérineau, Jean-Marc Pascussi and 2 more

Abstract read
In one paragraph

Article in Epilepsia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leonie RuntzLaboratory of Cerebrovascular Mechanisms of Brain Disorders, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Benoit GirardLaboratory of Pathophysiology of Synaptic Transmission, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Marion ToussenotLaboratory of Cerebrovascular Mechanisms of Brain Disorders, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Julie EspallerguesHistalim, Montpellier, France.
Alexis Fayd'Herbe De MaudaveLaboratory of Cerebrovascular Mechanisms of Brain Disorders, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Alexandre MilmanIon channels in Neuronal Excitability and Diseases, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Frederic deBockLaboratory of Cerebrovascular Mechanisms of Brain Disorders, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Chaitali GhoshCerebrovascular Research, Cleveland Clinic, Cleveland, OH, USA.
Nathalie C GuérineauIon channels in Neuronal Excitability and Diseases, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Jean-Marc PascussiLaboratory of Self-Renewal and Differentiation of Epithelia, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Federica BertasoLaboratory of Pathophysiology of Synaptic Transmission, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.
Nicola MarchiLaboratory of Cerebrovascular Mechanisms of Brain Disorders, Institute of Functional Genomics (UMR 5203 CNRS-U 1191 INSERM), Montpellier, France.

Funding

Drug brain biotransformation in human refractory epilepsyR01NS078307 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI GHOSH, CHAITALI, MARCHI, NICOLA · 2012 to 2016
$1.7M
NINDS NIH HHS R01 NS078307
6 · The paper itself

Abstract

objectiveAvailable evidence points to a role of cytochrome P450 (Cyp) drug biotransformation enzymes in central nervous system diseases, including epilepsy. Deviations in drug pharmacokinetic profiles may impact therapeutic outcomes. Here, we ask whether spontaneous recurrent seizure (SRS) activity is sufficient to modulate the expression of major Cyp enzymes in the liver and brain.

methodsUnilateral intrahippocampal (IH) kainic acid (KA) injections were used to elicit nonconvulsive status epilepticus (SE), epileptogenesis, and SRS, as monitored by video-electroencephalography. Intraperitoneal (IP) KA injection was used to trigger generalized tonic-clonic SE. KA-injected mice and sham controls were sacrificed at 24-72 hours and 1 week post-SE (IH or IP KA), and during the chronic stage (SRS; 6 weeks post-IH KA). Liver and brain tissues were processed for histology, real-time quantitative polymerase chain reaction, Western blot, or microsomal enzymatic assay. Cyp2e1, Cyp3a13, glial fibrillary acidic protein (GFAP), IBA1, xenobiotic nuclear receptors nr1i2 (PXR), nr1i3 (CAR) and nr3c1 (glucocorticoid receptor [GR]) expression was examined. Serum samples were obtained to assay corticosterone levels, a GR activator.

resultsA significant increase of Cyp3a13 and Cyp2e1 transcript level and protein expression was found in the liver and hippocampi during SRS, as compared to control mice. In the ipsilateral hippocampus, Cyp2e1 and Cyp3a protein upregulation during SRS positively correlated to GFAP expression. GFAP SIGNIFICANCE: SRS modifies Cyp expression in the liver and the hippocampus. Nuclear receptors or inflammatory pathways are candidate mechanisms of Cyp regulation during seizures.

Indexed as

AnimalsCalcium-Binding ProteinsConstitutive Androstane ReceptorCorticosteroneCytochrome P-450 Enzyme SystemDisease Models, AnimalDrug Administration RoutesExcitatory Amino Acid AgonistsFunctional LateralityGene Expression Regulation, EnzymologicGlial Fibrillary Acidic ProteinHippocampusKainic AcidLiverMaleMiceAif1 protein, mouseCalcium-Binding ProteinsConstitutive Androstane ReceptorCorticosteroneCytochrome P-450 Enzyme SystemExcitatory Amino Acid AgonistsGlial Fibrillary Acidic ProteinKainic AcidMicrofilament ProteinsNr1i3 protein, mouseReceptors, Cytoplasmic and NuclearRNA, Messengerdrug metabolismepilepsyinflammationliverP450

Identifiers

PMID29125184
PMCPMC5774654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.